MedPacto Statistics

Total Valuation

MedPacto has a market cap or net worth of KRW 127.85 billion. The enterprise value is 76.24 billion.

Market Cap	127.85B
Enterprise Value	76.24B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

MedPacto has 34.28 million shares outstanding. The number of shares has increased by 38.35% in one year.

Current Share Class	34.28M
Shares Outstanding	34.28M
Shares Change (YoY)	+38.35%
Shares Change (QoQ)	-1.14%
Owned by Insiders (%)	13.36%
Owned by Institutions (%)	4.03%
Float	25.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	297.36
PB Ratio	2.34
P/TBV Ratio	2.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.36
EV / Sales	177.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.24

Financial Position

The company has a current ratio of 59.04, with a Debt / Equity ratio of 0.00.

Current Ratio	59.04
Quick Ratio	57.54
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-189.41

Financial Efficiency

Return on equity (ROE) is -23.16% and return on invested capital (ROIC) is -15.87%.

Return on Equity (ROE)	-23.16%
Return on Assets (ROA)	-15.58%
Return on Invested Capital (ROIC)	-15.87%
Return on Capital Employed (ROCE)	-28.99%
Revenue Per Employee	7.05M
Profits Per Employee	-233.12M
Employee Count	61
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.21% in the last 52 weeks. The beta is 1.11, so MedPacto's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	-50.21%
50-Day Moving Average	3,497.90
200-Day Moving Average	4,367.53
Relative Strength Index (RSI)	47.47
Average Volume (20 Days)	194,196

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedPacto had revenue of KRW 429.94 million and -14.22 billion in losses. Loss per share was -422.51.

Revenue	429.94M
Gross Profit	-59.86M
Operating Income	-15.90B
Pretax Income	-14.22B
Net Income	-14.22B
EBITDA	-14.46B
EBIT	-15.90B
Loss Per Share	-422.51

Full Income Statement

Balance Sheet

The company has 51.63 billion in cash and 22.05 million in debt, giving a net cash position of 51.61 billion or 1,505.64 per share.

Cash & Cash Equivalents	51.63B
Total Debt	22.05M
Net Cash	51.61B
Net Cash Per Share	1,505.64
Equity (Book Value)	54.64B
Book Value Per Share	1,594.04
Working Capital	52.84B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.91 billion and capital expenditures -313.89 million, giving a free cash flow of -12.22 billion.

Operating Cash Flow	-11.91B
Capital Expenditures	-313.89M
Free Cash Flow	-12.22B
FCF Per Share	-356.51

Full Cash Flow Statement

Margins

Gross Margin	-13.92%
Operating Margin	-3,698.25%
Pretax Margin	-3,307.46%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MedPacto does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.35%
Shareholder Yield	n/a
Earnings Yield	-11.12%
FCF Yield	-9.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 13, 2020. It was a forward split with a ratio of 2.

Last Split Date	May 13, 2020
Split Type	Forward
Split Ratio	2

Scores

MedPacto has an Altman Z-Score of 109.91 and a Piotroski F-Score of 2.

Altman Z-Score	109.91
Piotroski F-Score	2